Announcement

Collapse
No announcement yet.

Nephron. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Nephron. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade


    Nephron. 2020 Mar 23:1-9. doi: 10.1159/000507305. [Epub ahead of print]
    Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.


    Perico L1, Benigni A1, Remuzzi G2,3.

    Author information




    Abstract

    Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.
    ? 2020 S. Karger AG, Basel.



    KEYWORDS:

    Angiotensin receptor blockers; Angiotensin-converting enzyme inhibitors; COVID-19; Renal and cardiac side effects; SARS-CoV-2; Severe acute respiratory syndrome coronavirus


    PMID:32203970DOI:10.1159/000507305

Working...
X